Carfilzomib 60mg Injection: A Targeted Therapy for Multiple Myeloma
This medicine belongs to the drug class of Proteasome Inhibitor. It is a newer cancer drug and a highly advanced therapy for patients with multiple myeloma, a form of blood cancer which affects the plasma cells in the bone marrow. This drug is commonly prescribed for patients with cancer which is relapsed or refractory to…